GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022
April 27 2022 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today
announced that it will report first quarter 2022 financial results
on Wednesday, May 4, 2022, after U.S. financial markets close.
Management will host a conference call on Wednesday, May 4,
2022, at 4:30 p.m. ET to discuss first quarter 2022 financial
results and to provide a business update. To participate in the
conference call, please dial 877-407-3982 (domestic) or +1
201-493-6780 (international). A live audio webcast can be accessed
on GBT’s website at www.gbt.com in the Investors section. The
archived audio webcast will be available for one month following
the event.
About Global Blood TherapeuticsGlobal Blood
Therapeutics (GBT) is a biopharmaceutical company dedicated to the
discovery, development and delivery of life-changing treatments
that provide hope to underserved patient communities, starting with
sickle cell disease (SCD). Founded in 2011, GBT is delivering on
its goal to transform the treatment and care of SCD, a lifelong,
devastating inherited blood disorder. The company has introduced
Oxbryta® (voxelotor), the first FDA-approved medicine that directly
inhibits sickle hemoglobin (HbS) polymerization, the root cause of
red blood cell sickling in SCD. GBT is also advancing its pipeline
program in SCD with inclacumab, a P-selectin inhibitor in Phase 3
development to address pain crises associated with the disease, and
GBT021601 (GBT601), the company’s next generation HbS
polymerization inhibitor. In addition, GBT’s drug discovery teams
are working on new targets to develop the next generation of
treatments for SCD. To learn more, please visit www.gbt.com and
follow the company on Twitter @GBT_news.
Contact:Steven Immergut
(media)650.410.3258simmergut@gbt.com
Courtney Roberts (investors)650.351.7881croberts@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Oct 2023 to Oct 2024